
    
      This phase I/II study of rhTSH, To observe the safety and tolerability characteristics of
      different doses of rhTSH In Post-thyroidectomized Patients, and to observe the dose-limiting
      toxicity (DLT) and maximum tolerated dose (MTD).
    
  